Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

BACKGROUND: Afghanistan's national guidelines recommend chloroquine for the treatment of Plasmodium vivax infection, the parasite responsible for the majority of its malaria burden. Chloroquine resistance in P. vivax is emerging in Asia. Therapeutic responses across Afghanistan have not been ev...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Awab, Ghulam Rahim, Pukrittayakamee, Sasithon, Imwong, Mallika, Dondorp, Arjen M, Woodrow, Charles J, Lee, Sue Jean, Day, Nicholas PJ, Singhasivanon, Pratap, White, Nicholas J, Kaker, Faizullah
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864284/
https://ncbi.nlm.nih.gov/pubmed/20409302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-9-105
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky